Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis.

作者: Paola De Feudis , Sara Vignati , Cosmo Rossi , Tatiana Mincioni , Raffaella Giavazzi

DOI: 10.1038/SJ.NEO.7900086

关键词:

摘要: The proapoptotic gene bax is one of the downstream effectors p53. p53 binding site in promoter less responsive to than growth arrest mediating p21. We introduced under control 13 copies a strong element into two ovarian cancer cell lines. clones expressing obtained from wild-type (wt) p53-expressing line A2780 were much more sensitive (500- 1000-fold) anticancer agent taxol parent line, with higher percentage cells undergoing apoptosis after drug treatment that was clearly p53-dependent and bax-mediated. Xenografts established nude mice selected clone (A2780/C3) parental apoptotic response A2780/C3 tumors also increased treatment. Introduction same plasmid null SKOV3 did not alter sensitivity or induction apoptosis. In conclusion, driving (after treatment) by activating rather p21 results massive apoptosis, vitro vivo, greatly enhances drug.

参考文章(33)
E. Boven, H. H. Fiebig, S. Langdon, M. P. Dumont, Ø. Fodstad, B. J. M. Braakhuis, B. Winograd, D. P. Berger, Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Research. ,vol. 52, pp. 5940- 5947 ,(1992)
Bert Vogelstein, Kenneth W. Kinzler, Todd Waldman, p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Research. ,vol. 55, pp. 5187- 5190 ,(1995)
Domizia Debernardis, Eva Graniela Siré, Paola De Feudis, Faina Vikhanskaya, Monica Valenti, Patrizia Russo, Silvio Parodi, Maurizio D'Incalci, Massimo Broggini, p53 Status Does Not Affect Sensitivity of Human Ovarian Cancer Cell Lines to Paclitaxel Cancer Research. ,vol. 57, pp. 870- 874 ,(1997)
Nancy L. Lill, Steven R. Grossman, Doron Ginsberg, James DeCaprio, David M. Livingston, Binding and modulation of p53 by p300/CBP coactivators Nature. ,vol. 387, pp. 823- 827 ,(1997) , 10.1038/42981
K. W. Kohn, D. J. Rivet, A. J. Fornace, Qimin Zhan, M. L. Smith, Saijun Fan, P. M. O'connor, D. Duba, Disruption of p53 Function Sensitizes Breast Cancer MCF-7 Cells to Cisplatin and Pentoxifylline Cancer Research. ,vol. 55, pp. 1649- 1654 ,(1995)
Thierry Rossé, Reynald Olivier, Laurent Monney, Monika Rager, Sébastien Conus, Isabelle Fellay, Burkhard Jansen, Christoph Borner, Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c Nature. ,vol. 391, pp. 496- 499 ,(1998) , 10.1038/35160
R. Giavazzi, M.I. Nicoletti, V. Lucchini, G. Massazza, B.J. Abbott, M. D'Incalci, Antitumor activity of taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice Annals of Oncology. ,vol. 4, pp. 151- 155 ,(1993) , 10.1093/OXFORDJOURNALS.ANNONC.A058419
Philip L. Simonian, Didier A. M. Grillot, David W. Andrews, Brian Leber, Gabriel Nuñez, Bax Homodimerization Is Not Required for Bax to Accelerate Chemotherapy-induced Cell Death Journal of Biological Chemistry. ,vol. 271, pp. 32073- 32077 ,(1996) , 10.1074/JBC.271.50.32073
Chaoying Yin, C. Michael Knudson, Stanley J. Korsmeyer, Terry Van Dyke, Bax suppresses tumorigenesis and stimulates apoptosis in vivo Nature. ,vol. 385, pp. 637- 640 ,(1997) , 10.1038/385637A0